Frankfurt, Hessen, Germany The fund was located in Europe if to be more exact in Germany. The main department of described Corporate Investor is located in the Frankfurt.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular fund investment industries, there are Health Care, Medical. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Siqens, Rodos BioTarget, TakWak. The fund has exact preference in some founders of portfolio startups.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the ERP Startfonds, startups are often financed by High-Tech Gru00fcnderfonds, Creathor Ventures, NRW.BANK. The meaningful sponsors for the fund in investment in the same round are Creathor Ventures, NRW.BANK, IBB Beteiligungsgesellschaft. In the next rounds fund is usually obtained by KfW, High-Tech Gru00fcnderfonds, Creathor Ventures.
This ERP Startfonds works on 21 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 1 - 5 millions dollars. The higher amount of exits for fund were in 2014. The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2010.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Implandata Ophthalmic Products | $1M | 30 Aug 2012 | Lower Saxony | ||
Intelligent Apps | 06 Jun 2011 | Germany, Baden-Württemberg, Germany | |||
tolingo | 24 May 2011 | Germany, Baden-Württemberg, Germany | |||
Caprotec Bioanalytics | $5M | 13 May 2010 | Berlin, Berlin, Germany | ||
CEVEC Pharmaceuticals | $5M | 02 Feb 2010 | Germany, North Rhine-Westphalia | ||
TakWak | $2M | 19 Jan 2010 | Germany, Bavaria, Germany | ||
| $4M | 19 Nov 2009 | Germany, North Rhine-Westphalia | |||
Caprotec Bioanalytics | $8M | 10 Jan 2008 | Berlin, Berlin, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Implandata Ophthalmic Products | $1M | 30 Aug 2012 | Lower Saxony | ||
Intelligent Apps | 06 Jun 2011 | Germany, Baden-Württemberg, Germany | |||
tolingo | 24 May 2011 | Germany, Baden-Württemberg, Germany | |||
Caprotec Bioanalytics | $5M | 13 May 2010 | Berlin, Berlin, Germany | ||
CEVEC Pharmaceuticals | $5M | 02 Feb 2010 | Germany, North Rhine-Westphalia | ||
TakWak | $2M | 19 Jan 2010 | Germany, Bavaria, Germany | ||
| $4M | 19 Nov 2009 | Germany, North Rhine-Westphalia | |||
Caprotec Bioanalytics | $8M | 10 Jan 2008 | Berlin, Berlin, Germany |
